LoginSignup
AbbVie logo

AbbVie

Stock
Stock
Ticker: ABBV
ABBV

Price

Price

CHART BY

Historical dividends and forecast

All dividend data

 The next dividend will be paid on 17.02.2026

$4.438

CHART BY

Frequently asked questions

What is AbbVie's market capitalization?

The market capitalization of AbbVie is $394.89B. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.

What is AbbVie's Price-to-Earnings (P/E) ratio?

The Price-to-Earnings (P/E) ratio (TTM) for AbbVie is 93.74. This ratio helps investors assess whether a stock is overvalued or undervalued compared to its earnings.

What is the Earnings Per Share (EPS) for AbbVie?

AbbVie's Earnings Per Share (EPS) over the trailing twelve months (TTM) is $2.367. EPS indicates the company's profitability on a per-share basis.

What are the analyst ratings and target price for AbbVie's stock?

Currently, 32 analysts cover AbbVie's stock, with a consensus target price of $251.46. Analyst ratings provide insights into the stock's expected performance.

What is AbbVie's revenue over the trailing twelve months?

Over the trailing twelve months, AbbVie reported a revenue of $61.16B.

Is AbbVie paying dividends?

Yes, AbbVie is paying dividends. The next payment is scheduled for 17.02.2026, with an expected amount of .

What is the free float of AbbVie's shares?

The free float of AbbVie is 1.77B. Free float refers to the number of shares available for public trading, excluding restricted shares.

Financials

Market Cap 
$394.89B
EPS (TTM) 
$2.367
Free Float 
1.77B
P/E ratio (TTM) 
93.74
Revenue (TTM) 
$61.16B

Pricing

1D span
$218.71$225.80
52W span
$164.39$244.80

Analyst Ratings

The price target is $251.46 and the stock is covered by 32 analysts.

Buy

20

Hold

11

Sell

1

Information

AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology, and dermatology, oncology, including blood cancers, virology, hepatitis C virus (HCV) and human immunodeficiency virus (HIV), neurological disorders, such as Parkinson's, metabolic, comprising thyroid disease and complications associated with cystic fibrosis, pain associated with endometriosis, and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL.

Industries
Major Pharmaceuticals
Sector
Health Care

Identifier

Primary Ticker
ABBV

Knockouts

Real-time data from LSX · Fundamentals & EOD data from FactSet
Join the conversation
Sign upLogin